0001567619-22-019198.txt : 20221104 0001567619-22-019198.hdr.sgml : 20221104 20221104162708 ACCESSION NUMBER: 0001567619-22-019198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221103 FILED AS OF DATE: 20221104 DATE AS OF CHANGE: 20221104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Francisco CENTRAL INDEX KEY: 0001527241 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37603 FILM NUMBER: 221362657 MAIL ADDRESS: STREET 1: STEM CELL ASSURANCE, INC. STREET 2: 555 HERITAGE DRIVE CITY: JUPITER STATE: FL ZIP: 33458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioRestorative Therapies, Inc. CENTRAL INDEX KEY: 0001505497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 911835664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 760-8100 MAIL ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Stem Cell Assurance, Inc. DATE OF NAME CHANGE: 20101110 4 1 doc1.xml FORM 4 X0306 4 2022-11-03 0 0001505497 BioRestorative Therapies, Inc. BRTX 0001527241 Silva Francisco 40 MARCUS DRIVE MELVILLE NY 11747 1 1 0 0 VP of Research and Development Common Stock 165103 D Common Stock 12136 I IRA Stock Option 3000. 2022-12-07 Common Stock 1 1 D Stock Option 3000. 2023-10-04 Common Stock 1 1 D Stock Option 3000. 2024-02-18 Common Stock 3 3 D Stock Option 3000 2014-03-12 2024-03-11 Common Stock 1 1 D Stock Option 3000 2024-10-23 Common Stock 9 9 D Stock Option 3000 2025-09-04 Common Stock 6 6 D Stock Option 3000 2026-06-10 Common Stock 15 15 D Stock Option 3000 2027-07-12 Common Stock 20 20 D Stock Option 3000 2028-10-29 Common Stock 25 25 D Stock Option 13.5 2022-11-03 4 D 0 293479 0 D 2031-03-18 Common Stock 293479 0 D Stock Option 5.08 2022-11-03 4 A 0 293479 0 A 2031-03-18 Common Stock 293479 293479 D Stock Option 13.5 2022-11-03 4 D 0 42059 0 D 2031-11-04 Common Stock 42059 0 D Stock Option 5.08 2022-11-03 4 A 0 42059 0 A 2031-11-04 Common Stock 42059 42059 D Includes 103,008 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on November 18, 2022 and January 18, 2023, 1,037 shares on December 18, 2022 and February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024. The option is currently exercisable. The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested. The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022. The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price. /s/ Francisco Silva 2022-11-03